• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    A

    AHEPA University Hospital

    EST. 1947
    3,073论文总数
    6.5万引用总数

    The AHEPA University General Hospital (Greek: Πανεπιστημιακό Νοσοκομείο ΑΧΕΠΑ), also known as AHEPA Hospital, is considered one of the biggest hospitals in Greece, based in Thessaloniki. Covers 680 beds and all the spectrum of medical and surgical specialities of medicine as well as the psychiatric sector. Is associated with the 4th Health District of Health Services of Macedonia and Thrace as an independent service, with administrative and economic autonomy. The central service of AHEPA hospital is located in the territory of Aristotle University of Thessaloniki, within the administrative region of the municipality of Thessaloniki. It is a major teaching hospital and part of the ESY (Greek: ΕΣΥ - Εθνικό Σύστημα Υγείας), the National Healthcare System of Greece. The structured areas of the hospital cover 50,000 sqm, built in several time points, to cope with the emerging needs..

    论文量&引用量时间轴

    机构学者

    论文(3073)

    年份
    起
    –
    止
    排序
    1Does Preoperative Administration of Lugol's Solution in Patients Undergoing Thyroidectomy for Graves' Disease Really Improve Surgical Outcomes? A Propensity Score Matching Analysis from Six High-Volume Centers (stellina Study).
    Gian Luigi Canu,Fabio Medas, Federico Cappellacci, Giulia Lanzolla,Leonardo Rossi,Francesco Pennestrì, Giacomo Di Filippo,Angeliki Chorti,Benard Gjeloshi,Annamaria Martullo,Ioannis Pliakos,Giovanni Lazzari,

    In patients with Graves’ disease, the 2016 American Thyroid Association guidelines and 2018 European Thyroid Association guidelines recommend the administration of Lugol’s solution prior to surgery. The objective of this study was to evaluate whether preoperative administration of this solution in patients undergoing thyroidectomy for Graves’ disease really improves surgical outcomes. Patients who underwent total thyroidectomy for Graves’ disease, performed by high-volume surgeons, in six European centers, between 2019 and 2023, were retrospectively evaluated. Based on preoperative administration of Lugol’s solution, two groups were identified: LS Group, including patients who received this solution, and NoLS Group, including those who did not receive it. Surgical outcomes were assessed after performing propensity score matching (1:1). According to the inclusion criteria, 1380 patients were enrolled: 622 in LS Group and 758 in NoLS Group. After propensity score matching, the study population consisted of 494 patients: 247 in LS Group and 247 in NoLS Group. Regarding complications, neck hematomas managed conservatively were significantly greater in NoLS Group (P = 0.016); while unilateral recurrent laryngeal nerve injury, overall postoperative hypoparathyroidism, and temporary hypoparathyroidism were significantly greater in LS Group (P = 0.026, P < 0.001, P < 0.001; respectively). The duration of surgery and postoperative hospital stay were significantly longer in LS Group (P < 0.001, P < 0.001; respectively). Based on our findings and those of other authors, we believe that the recommendations of existing guidelines should be revised.

    2026Updates in Surgery(2026)引用:19
    引用
    AI阅读
    加入学术空间
    2Predicting Disease Progression in Multiple Sclerosis with Clinically Accessible Information and Technology
    Tom A. N. Fuchs,Menno M. Schoonheim, Eva M. M. Strijbis, Julia R. Jelgerhuis,Dana Horakova, Eva K. Havrdova,Tomas Uher,Robert Zivadinov,Serkan Ozakbas,Marc Girard,Raed Alroughani,Pierre Grammond,

    Predicting disease progression at the individual level is essential for personalized medicine. We previously developed machine-learning tools to estimate 5-year progression risk in people with multiple sclerosis (PwMS). Such models should account for disease-modifying therapy (DMT) and objective outcome definitions. In a retrospective multicenter case–control study, we evaluated adults with relapsing–remitting multiple sclerosis (RRMS) at baseline. Using machine-learning, we developed two complementary tools for individualized 5-year risk estimation: DAAE-M, optimized for transparency, software-neutral use, and mitigation of indication bias, and ELIE, optimized for dynamic landmark-based modeling, complex treatment histories, and mitigation of immortal-time bias. Disease progression was defined using both a clinical outcome (RRMS-to-progressive MS) and an objective outcome (late-stage confirmed progression independent of relapse activity). Among 34,510 people with RRMS (72.6

    2026Journal of Neurology(2026)引用:2
    引用
    AI阅读
    加入学术空间
    3The Role of Kupffer Cells and Liver Macrophages in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Ioannis Tsomidis, Angeliki Tsakou,Argyro Voumvouraki,Elias Kouroumalis

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is a continuum of hepatic pathological manifestations of the metabolic syndrome. Pathogenesis is not clearly understood despite recent progress, but Kupffer cells and bone marrow-derived macrophages (BMDMs) have a fundamental role. In this review, the multiple pathophysiological aspects of MASLD are presented, including genetics, insulin resistance, lipotoxicity, and inflammation. The participation of innate and adaptive immunity, as well as the implications of the recently described trained immunity, is presented. The interplay of the liver with the gut microbiota is also analyzed. A recent adipocentric theory and the various mechanisms of hepatocyte death are also described. The fundamental role of Kupffer cells and other liver macrophages is discussed in detail, including their extreme phenotypic plasticity in both the normal and the MASLD liver. The functional differentiation between pro-inflammatory and anti-inflammatory subpopulations and their protective or detrimental involvement is further described, including the participation of Kupffer cells and BMDMs in all aspects of MASLD pathogenesis. The role of macrophages in the development of advanced MASLD, including fibrosis and hepatocellular carcinoma, is analyzed and the lack of explanation for the transition from MASLD to MASH is recognized. Finally, current modalities of drug treatment are briefly presented and the effects of different drugs on macrophage polarization and functions are discussed.

    2026Biomedicines(2026)引用:2
    引用
    AI阅读
    加入学术空间
    4Mechanical Circulatory Support in Cardiogenic Shock: a Contemporary Head-to-head Comparison
    Stavroula A. Siopi,Polychronis Antonitsis,Georgios T. Karapanagiotidis,Georgios Tagarakis,Christos Voucharas,Kyriakos Anastasiadis

    Modern technology has expanded the armamentarium of temporary mechanical circulatory support devices implemented for hemodynamic stabilization of patients in cardiogenic shock. The predominately used ones are intra-aortic balloon pump (IABP), Impella devices, and extracorporeal life support (ECLS) circuits. They are transcutaneous or surgically implanted, utilized for up to 30 days and can either assist or totally replace cardiac function, providing time for myocardial healing (bridge to recovery) or treatment escalation (bridge to destination therapy, bridge to transplantation). In light of the recently published joint consensus of the Perioperative Quality Initiative and Enhanced Recovery After Surgery Cardiac Society on temporary mechanical circulatory support, purpose of the current review is to provide a succinct head-to-head comparison of widely available devices, as well as current escalation, de-escalation and antithrombotic protocols; thus, it proposes immediately translatable device selection and operation algorithms to medical professionals for optimal patient care and effective management of cardiogenic shock.

    2026Heart Failure Reviews(2026)引用:1
    引用
    AI阅读
    加入学术空间
    5Impact of an Intradialytic Non-immersive Virtual Reality Platform on Functional Capacity: the GoodRENal Pilot Feasibility Study
    Eva Segura-Orti,Evangelia Kouidi, Vasiliki Michou, Alicia Cana-Poyatos, Francisco J Martínez-Olmos, Noemí Valtueña-Gimeno, Carla M Avesani,Patricia Mesa-Gresa,Naomi Clyne, José A Lozano-Quilis, José A Gil-Gómez,Amaryllis H Van Craenenbroeck,

    Rationale & Objective:Sedentarism and low health-related quality of life (HRQoL) are common in people receiving hemodialysis, and innovative approaches are needed to improve HRQoL. Aims:We investigated the feasibility and safety of an intradialytic exercise intervention using the GoodRENal virtual reality platform in people receiving hemodialysis and tested the impact on physical function and muscle strength. Study Design:In a randomized control trial of feasibility and safety, participants were enrolled into a 4-to 12-week intradialytic exercise and were randomly allocated to a usual care control group (CG) or GoodRENal intervention group (GIG). Setting & Participants:Participants were recruited from two hemodialysis units in Spain and Greece. Exposure:GIG was exposed to a platform delivered via laptop consisting of several virtual reality scenarios (serious games) for physical activity, nutritional information, psychological well-being, and cognitive function. Outcomes:The primary outcomes for feasibility were recruitment, retention, and adherence rates. Physical performance and lower-limb muscle strength were assessed at baseline and at follow-up. Analytical Approach:A two-way repeated-measures analysis of variance was applied. Results:Forty-one patients (64.5 ± 13.3 years; women 29.3%) were randomized. The recruitment rate (recruited participants / potential identified participants) was 53.2%. The retention ranged from 91% to 100%. Adherence ranged from 61% to 100%. No adverse effects were reported. Gait speed decreased significantly in CG participants (-0.06 m/s). A significant increase in lower-limb muscle strength was found in the GIG (change in hip flexors, 29.3 N; hip abductors, 27.4 N) after 12 weeks of participation, but not in the CG. Limitations:These results are based on a small sample and the games were not developed by a videogame company. Conclusions:The GoodRENal platform is a feasible and safe intervention to promote intradialytic exercise and results in increased lower-limb muscle strength. Future research should determine the effectiveness by recruitment of a larger sample for a longer period of intervention. Implications for the profession and/or patient care:An intradialytic nonimmersive virtual reality platform that promotes a healthy lifestyle (diet, physical activity, and good cognitive and psychological state) is feasible and safe. A holistic approach involving patients and health care professionals is important to overcome barriers to a healthier lifestyle while receiving HD. Enhancing competencies of renal nurses on physical activity promotion might improve the healthy lifestyle of patients receiving HD. The implementation of the GoodRENal platform resulted in increased lower-limb muscle strength and preserved gait speed. What does this paper contribute to the wider global clinical community?:•People receiving hemodialysis are sedentary. Encouraging patients receiving dialysis to increase their physical activity is difficult; thus, it is important to create/develop ways to facilitate their engagement in physical activity.•A nonimmersive virtual reality intradialytic platform is feasible and safe and resulted in an increase in lower-limb muscle strength and preserved gait speed in people receiving hemodialysis.•Because sarcopenia and frailty are highly prevalent, dialysis units should consider integrating intradialytic training for all medically stable patients. Reporting Method:We have adhered to relevant EQUATOR guidelines (CONSORT). Patient or Public Contribution:Patients and renal nurses answered a satisfaction questionnaire with the GoodRENal platform use.

    2026Kidney medicine(2026)引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3073 篇论文

    合作机构(100)

    亚里士多德大学合作论文 911
    雅典国立和卡波迪斯蒂安大学合作论文 235
    约阿尼纳大学合作论文 100
    色雷斯德谟克利特大学合作论文 93
    塞萨洛尼基大学合作论文 75
    University General Hospital Attikon合作论文 69
    University Hospital of Larissa合作论文 60
    帕特拉斯大学合作论文 58
    University Hospital of Alexandroupolis合作论文 56
    G. Papanikolaou General Hospital合作论文 50

    机构统计